dapsone has been researched along with Lupus Erythematosus, Discoid in 15 studies
Lupus Erythematosus, Discoid: A chronic form of cutaneous lupus erythematosus (LUPUS ERYTHEMATOSUS, CUTANEOUS) in which the skin lesions mimic those of the systemic form but in which systemic signs are rare. It is characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy. Lesions are surrounded by an elevated erythematous border. The condition typically involves the face and scalp, but widespread dissemination may occur.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a hitherto unreported laboratory observation, namely the selective preservation of basophils, in a case of severe dapsone-induced agranulocytosis." | 7.75 | Preservation of basophils in dapsone-induced agranulocytosis suggests a possible pathogenetic role for leucocyte peroxidases. ( Beatty, C; Besser, M; Chitnavis, D; Clark, J; Vassiliou, G; Vera, J, 2009) |
| "We describe a hitherto unreported laboratory observation, namely the selective preservation of basophils, in a case of severe dapsone-induced agranulocytosis." | 3.75 | Preservation of basophils in dapsone-induced agranulocytosis suggests a possible pathogenetic role for leucocyte peroxidases. ( Beatty, C; Besser, M; Chitnavis, D; Clark, J; Vassiliou, G; Vera, J, 2009) |
| "The dapsone treatment gave excellent results in 8 patients (24%), some effect in 8 patients (24%), while no response was seen in 17 patients (52%)." | 2.66 | Dapsone in the treatment of cutaneous lupus erythematosus. ( Lindskov, R; Reymann, F, 1986) |
| " After a 2-month course of treatment with hydroxychloroquine dosage of 200 mg per day and a break of 3 months between courses, we observed a complete remission." | 1.43 | Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem. ( Bakardzhiev, I; Chokoeva, AA; Krasnaliev, I; Lotti, T; Tana, C; Tchernev, G; Wollina, U, 2016) |
| "We describe a patient with systemic lupus erythematosus (SLE) who exhibited severe cutaneous involvement characterized by the simultaneous presence of acute, subacute and discoid lesions in association with anti-S1 antibodies." | 1.30 | A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone. ( Bernacchi, E; Bombardieri, S; Mosca, M; Neri, R, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakardzhiev, I | 1 |
| Chokoeva, AA | 1 |
| Krasnaliev, I | 1 |
| Tana, C | 1 |
| Wollina, U | 1 |
| Lotti, T | 1 |
| Tchernev, G | 1 |
| Garza-Mayers, AC | 1 |
| McClurkin, M | 1 |
| Smith, GP | 1 |
| Besser, M | 1 |
| Vera, J | 1 |
| Clark, J | 1 |
| Chitnavis, D | 1 |
| Beatty, C | 1 |
| Vassiliou, G | 1 |
| Francès, C | 1 |
| Barete, S | 1 |
| Ayoub, N | 1 |
| Piette, JC | 1 |
| Stavropoulos, PG | 1 |
| Moustou, AE | 1 |
| Tsiougou, M | 1 |
| Avgerinou, G | 1 |
| Chatziolou, E | 1 |
| Katsambas, A | 1 |
| McCormack, LS | 1 |
| Elgart, ML | 1 |
| Turner, ML | 1 |
| Coburn, PR | 1 |
| Shuster, S | 1 |
| Jakes, JT | 1 |
| Dubois, EL | 1 |
| Quismorio, FP | 1 |
| Ruzicka, T | 1 |
| Goerz, G | 1 |
| Szeremeta, W | 1 |
| Dohar, JE | 1 |
| Callen, JP | 1 |
| Neri, R | 1 |
| Mosca, M | 1 |
| Bernacchi, E | 1 |
| Bombardieri, S | 1 |
| Lo, JS | 1 |
| Berg, RE | 1 |
| Tomecki, KJ | 1 |
| Lindskov, R | 1 |
| Reymann, F | 1 |
| Vandersteen, PR | 1 |
| Jordon, RE | 1 |
3 reviews available for dapsone and Lupus Erythematosus, Discoid
| Article | Year |
|---|---|
Review of treatment for discoid lupus erythematosus.
Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Dapsone; Humans; Hydroxychloroquine; Laser Therapy; | 2016 |
Treatment of cutaneous lesions in patients with lupus erythematosus.
Topics: Adrenal Cortex Hormones; Antimalarials; Azathioprine; Combined Modality Therapy; Dapsone; Drug Thera | 1994 |
Treatment of discoid lupus erythematosus.
Topics: Antimalarials; Dapsone; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Lupus Erythematosus | 1989 |
1 trial available for dapsone and Lupus Erythematosus, Discoid
| Article | Year |
|---|---|
Dapsone in the treatment of cutaneous lupus erythematosus.
Topics: Adult; Aged; Clinical Trials as Topic; Dapsone; Follow-Up Studies; Humans; Hydroxychloroquine; Lupus | 1986 |
11 other studies available for dapsone and Lupus Erythematosus, Discoid
| Article | Year |
|---|---|
Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Biopsy; Chloroquine; Combined Modality Therapy; Dapson | 2016 |
Preservation of basophils in dapsone-induced agranulocytosis suggests a possible pathogenetic role for leucocyte peroxidases.
Topics: Adult; Agranulocytosis; Basophils; Dapsone; Female; Humans; Leukocytes; Lupus Erythematosus, Discoid | 2009 |
[Classification of dermatologic manifestations in lupus erythematosus].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermato | 2003 |
Might dermatitis herpetiformis be associated with discoid lupus erythematosus?
Topics: Dapsone; Dermatitis Herpetiformis; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Male; M | 2008 |
Annular subacute cutaneous lupus erythematosus responsive to dapsone.
Topics: Acute Disease; Aged; Child, Preschool; Dapsone; Facial Dermatoses; Female; Follow-Up Studies; Humans | 1984 |
Dapsone and discoid lupus erythematosus.
Topics: Adolescent; Adult; Aged; Dapsone; Female; Humans; Lupus Erythematosus, Discoid; Male; Middle Aged; P | 1982 |
Antileprosy drugs and lupus erythematosus.
Topics: Clofazimine; Dapsone; Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic | 1982 |
Dapsone in the treatment of lupus erythematosus.
Topics: Adult; Child; Dapsone; Female; Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; | 1981 |
Dapsone-induced methemoglobinemia: an anesthetic risk.
Topics: Adolescent; Anesthesia, General; Dapsone; Female; Humans; Lupus Erythematosus, Discoid; Methemoglobi | 1995 |
A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Female; Hum | 1999 |
Dermatitis herpetiformis with discoid lupus erythematosus. Occurrence of sulfone-induced discoid lupus erythematosus.
Topics: Aged; Animals; Antibodies; Antibodies, Antinuclear; Basement Membrane; Dapsone; Dermatitis Herpetifo | 1974 |